This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

GEM - sickle cell answer part 7

Authoring team

  • in high prevalence areas every pregnant woman is offered screening to see if she is a carrier of a sickle cell or other haemoglobin variant (using HPLC). In lower prevalence area this test is offered selectively according to ancestry (using a standard family origin questionnaire). Rural Devon would be a low prevalence area. Universal screening is offered for sickle cell on the newborn blood spot test. The aim is the early detection and early treatment of affected children, hence to reduce morbidity and mortality. However many newborn carriers of haemoglobin disorders will also be identified (greater than 8,500 per year in England). The screening programme may also produce other information such as variants of unknown clinical significance and suggest non-paternity

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.